eFFECTOR Therapeutics

+$0.01 (+0.09%) As of 6:43 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EFTR and other ETFs, options, and stocks.

About EFTR

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2).

CEO
Stephen T. Worland
Employees
13
Headquarters
San Diego, California
Founded
2012

EFTR Key Statistics

Market Cap
478.68M
Price-Earnings Ratio
1.06K
Dividend Yield
—
Average Volume
693.99K
High Today
$12.16
Low Today
$11.52
Open Price
$11.61
Volume
69.39K
52 Week High
$40.42
52 Week Low
$8.33

EFTR Earnings

Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure